^
    BIOMARKER:

    TNFRSF8 positive

    i
    Other names: TNFRSF8, TNF Receptor Superfamily Member 8, Tumor Necrosis Factor Receptor Superfamily Member 8, Lymphocyte Activation Antigen CD30, CD30L Receptor, Ki-1 Antigen, D1S166E, CD30, Tumor Necrosis Factor Receptor Superfamily, Member 8, Cytokine Receptor CD30, CD30 Antigen, TNFRSF8, Ki-1
    Contact us to learn more about our Premium Content:
    News alerts, weekly reports and conference planners
    Entrez ID:
    943
    Related biomarkers:
    Expression
    Others
    TNFRSF8 positive
    Hodgkin Lymphoma
    CD30-targeted CAR-T immunotherapy
    Sensitive
    :
    C3
    SOHO 2022 - 6 days - (New C3)
    TNFRSF8 positive
    Hodgkin Lymphoma
    brentuximab vedotin
    Sensitive
    :
    A1
    TNFRSF8 positive
    Cutaneous T-cell Lymphoma
    brentuximab vedotin
    Sensitive
    :
    A1
    TNFRSF8 positive
    Diffuse Large B Cell Lymphoma
    brentuximab vedotin
    Sensitive
    :
    A2
    TNFRSF8 positive
    Peripheral T-cell Lymphoma
    brentuximab vedotin
    Sensitive
    :
    A2
    TNFRSF8 positive
    Non-Hodgkin’s Lymphoma
    TT11
    Sensitive
    :
    C2
    TNFRSF8 positive
    Lymphoma
    AFM13
    Sensitive
    :
    C2
    TNFRSF8 positive
    Hodgkin Lymphoma
    AFM13
    Sensitive
    :
    C2
    TNFRSF8 positive
    Hodgkin Lymphoma
    TT11
    Sensitive
    :
    C3
    TNFRSF8 positive
    Peripheral T-cell Lymphoma
    BV-ICE
    Sensitive
    :
    C3
    TNFRSF8 positive
    Lymphoma
    T-lymphocyte cell therapy
    Sensitive
    :
    D